Protocol · Neurological Health
Huntington's Disease Supportive Care Protocol
Coenzyme Q10 and Creatine are the core of this stack, with 7 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Huntington's Disease Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
9 supplements · none graded yet
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file |
|---|---|---|---|---|
| Primary stackThe core of this protocol | ||||
| Coenzyme Q10 | Amount listed: 600–1,200 mg daily | Supports mitochondrial function which is impaired in Huntington's; has neuroprotective potential | Not graded yet | |
| Creatine | Amount listed: 10–40 g daily (large trials used 8–40 g) | May support brain energy metabolism; studied for neuroprotection in Huntington's
| Not graded yet | |
| Supporting stackListed as additions to the core | ||||
| Omega-3 Fatty Acids | Amount listed: 2–4 g EPA+DHA daily | May have neuroprotective effects through anti-inflammatory mechanisms | Not graded yet | |
| Vitamin E | Amount listed: 400–2,000 IU daily | Antioxidant that may help protect against oxidative stress in neurodegeneration | Not graded yet | |
| Resveratrol | Amount listed: 200–1,000 mg daily | SIRT1 activator with potential neuroprotective effects; studied in HD models | Not graded yet | |
| Vitamin D | Amount listed: 2,000–4,000 IU daily (target 40–60 ng/mL) | Deficiency common; vitamin D has neuroprotective and anti-inflammatory effects | Not graded yet | |
| Curcumin | Amount listed: 500–1,500 mg bioavailable form daily | Anti-inflammatory and antioxidant; shown protective in HD animal models | Not graded yet | |
| B Vitamins | Amount listed: B-complex with B12 1,000 mcg, folate 800 mcg daily | Support energy metabolism and may help with fatigue and cognitive function | Not graded yet | |
| N-Acetylcysteine (NAC) | Amount listed: 600–1,800 mg daily | Glutathione precursor that may reduce oxidative stress in neurodegeneration | Not graded yet | |
How this protocol works
In plain language
Huntington's disease (HD) is an inherited neurodegenerative disorder caused by a mutation in the huntingtin gene (expanded CAG repeats). It typically begins in middle age (30s-40s) and causes progressive movement problems (chorea - involuntary movements), cognitive decline, and psychiatric symptoms. The disease gradually affects the basal ganglia and cortex of the brain. Currently, there is no cure and no treatment that slows the disease progression, though symptoms can be managed.
CRITICAL: Huntington's disease requires specialized neurology care, preferably at an HD center. Standard treatments manage symptoms (tetrabenazine/deutetrabenazine for chorea, antidepressants, antipsychotics as needed). Gene-silencing therapies are in development. Genetic counseling is essential for family members. These supplements are experimental and supportive only - they have NOT been proven to slow disease progression.
Coenzyme Q10* has been the most studied supplement in HD. The disease involves mitochondrial dysfunction and energy deficits, and CoQ10 supports mitochondrial function. While early studies were promising, larger trials have shown mixed results. It remains one of the most commonly used supplements among HD patients.
Creatine* supports brain energy metabolism. The CREST-E trial studied high-dose creatine but did not show significant benefit in slowing disease progression. However, it may still provide energy support.
Omega-3 Fatty Acids* have anti-inflammatory and potentially neuroprotective effects. A pilot study in HD patients showed some benefit, but larger studies are needed.
Vitamin E* is an antioxidant that may help with oxidative stress, which contributes to neurodegeneration in HD.
Resveratrol* activates SIRT1 and has shown protective effects in HD animal models, though human data is limited.
Vitamin D* deficiency is common in HD patients, partly due to reduced sun exposure. Maintaining adequate levels supports overall health.
Curcumin* has shown promise in HD animal models through its anti-inflammatory effects.
B Vitamins* support energy metabolism and overall brain health.
NAC* is a glutathione precursor that may help with oxidative stress.
Expected timeline: No supplements have been proven to slow HD progression. They may provide supportive benefit for energy, mood, and general health. Clinical trials of new disease-modifying therapies are ongoing.